Life-extension therapy: Long ncRNA MEG3  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 1/September/2017, 11.01 pm

Life-extension therapy: Long ncRNA MEG3  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 1/September/2017, 11.01 pm

Life-extension therapy: Long ncRNA MEG3  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 1/September/2017, 11.01 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that: Life-extension therapy: Long ncRNA MEG3  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes


Research findings to Therapeutic opportunity: 

Figure 1. Mechanistic insight into how MEG3 may extend lifespan. MEG3 may promote longevity by suppressing the expression of p70 S6 kInase

Long ncRNA MEG3, by  regulating  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing MEG3 or its activators, either alone or in combination with any of the known longevity-promoting compound(s)” may be used to extend the lifespan of an individual (fig. 1).

 

 


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How MEG3  decreases the expression of p70 S6 Kinase and promotes mammalian life span

# Research cooperation

Amount: $100#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L.,    Life-extension therapy: Long ncRNA MEG3  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 1/September/2017, 11.01 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org